1-3 of 3
C.E. Bulabois
Close
Sort by
Journal Articles

Cord Blood Transplantation after Non Myeloablative Conditioning (Minneapolis Protocol): Impact on Transplant Outcomes in 112 Adults with Hematologic Malignancy. A French Multicentric Study of the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC) and Eurocord.

B. Rio, D. Blaise, M. Renaud, M. Uzunov, J.H. Bourhis, P. Ceballos, S. Maury, C.E. Bulabois, L. Fouillard, E. Deconinck, N. Dhedin, A. Sirvent, M. Michallet, N. Contentin, A. Huynh, A. Buzyn, S. Francois, R. Tabrizi, I. Yakoub-Agha, P. Chevalier, T. de Revel, S. Lapusan, F. Garnier, K. Boudjedir, Eliane Gluckman, V. Rocha
Journal: Blood
Blood (2007) 110 (11): 2029.
https://doi.org/10.1182/blood.V110.11.2029.2029
Published: 2007
Journal Articles

No Benefit of Adding High-Dose Melphalan (HDM) Suppported by Autologous Stem Cell Transplantation (SCT) over Treatment with Conventional Induction, HD ARAC Consolidation, and Auto SCT (Busulfan + HDM) for Acute Myelogenous Leukemia (AML) under 60: First Results of the Randomized AML 2001 Trial.

B. Lioure, A. Pigneux, C. Recher, F. Witz, T. Lamy, N. Fegueux, C.E. Bulabois, N. Ifrah, I. Luquet, D. Bouscary, N. Vey, M. Delain, J.O. Bay, P. Turlure, Jean-Luc Harousseau
Journal: Blood
Blood (2006) 108 (11): 608.
https://doi.org/10.1182/blood.V108.11.608.608
Published: 2006
Journal Articles

Value of Early Evaluation with FDG-PET for Follicular Lymphoma.

Remy R. Gressin, MD, Jean Philippe J.P. Vuilliez, PhD, Lysiane L. Molina, MD, Brigitte B. Pegourie, MD, Stephane S. Courby, MD, Frederic F. Garban, PhD, Claude Eric C.E. Bulabois, MD, Frederique F. Orsini, MD, Emmanuelle E. Nicolas, Caroline C. Makowski, MD, Jean Jacques J.J. Sotto, PhD, Jean Yves J.Y. Cahn, PhD
Journal: Blood
Blood (2005) 106 (11): 4718.
https://doi.org/10.1182/blood.V106.11.4718.4718
Published: 2005